NASDAQ: RLMD
Relmada Therapeutics Inc Stock Ownership - Who owns Relmada Therapeutics?

Insider buying vs selling

Have Relmada Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Maged ShenoudaChief Financial Officer2025-05-2060,000$0.52
$31.44kBuy
Sergio TraversaChief Executive Officer2025-05-20147,686$0.56
$82.26kBuy
Maged ShenoudaChief Financial Officer2025-05-1990,000$0.49
$43.65kBuy
Sergio TraversaChief Executive Officer2025-05-1930,000$0.50
$15.00kBuy
Maged ShenoudaChief Financial Officer2025-05-1650,000$0.44
$22.10kBuy
Chuck EnceCA and CO2025-05-16228,961$0.45
$103.26kBuy
Paul Edward KellyChief Operating Officer2025-05-16200,000$0.43
$86.00kBuy
Sergio TraversaChief Executive Officer2025-05-16172,314$0.45
$77.54kBuy
Sergio TraversaChief Executive Officer2024-09-1151,407$2.99
$153.71kBuy
Maged ShenoudaChief Financial Officer2024-09-1124,120$2.95
$71.15kBuy

1 of 2

RLMD insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RLMD insiders and whales buy or sell their stock.

RLMD Shareholders

What type of owners hold Relmada Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Acadian Asset Management LLC3.70%1,227,928$749.04kInstitution
Vanguard Group Inc3.64%1,208,075$736.93kInstitution
Sergio Traversa2.21%734,024$447.75kInsider
Blackrock Inc1.71%566,905$345.81kInstitution
Palo Alto Investors LP1.49%495,146$302.04kInstitution
Paul Edward Kelly1.24%412,295$251.50kInsider
Geode Capital Management LLC0.91%301,883$184.15kInstitution
Maged Shenouda0.87%288,335$175.88kInsider
Two Sigma Advisers LP0.87%288,000$175.68kInstitution
Advisorshares Investments LLC0.83%276,514$168.67kInstitution

1 of 3

RLMD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RLMD18.74%6.73%Net BuyingNet Buying
MRKR2.89%97.11%Net Buying
SLGL100.00%0.00%
CING1.74%98.26%Net Selling
CRIS7.55%92.45%

Relmada Therapeutics Stock Ownership FAQ

Who owns Relmada Therapeutics?

Relmada Therapeutics (NASDAQ: RLMD) is owned by 18.74% institutional shareholders, 6.73% Relmada Therapeutics insiders, and 74.53% retail investors. Sergio Traversa is the largest individual Relmada Therapeutics shareholder, owning 734,024.00 shares representing 2.21% of the company. Sergio Traversa's Relmada Therapeutics shares are currently valued at $449.22k.

If you're new to stock investing, here's how to buy Relmada Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.